Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 78.92%157.28M | 149.93%457.05M | 77.54%135.41M | 372.26%125.73M | 309.01%118.9M | 72.69%87.91M | -3.15%182.87M | 116.53%76.27M | -36.59%26.62M | -31.78%29.07M |
| Cost of revenue | 77.35%145.37M | 161.09%422.31M | 82.69%123.74M | 416.32%117.3M | 328.99%110.65M | 76.55%81.97M | -8.33%161.75M | 109.71%67.74M | -41.53%22.72M | -35.54%25.79M |
| Gross profit | 100.54%11.92M | 64.46%34.74M | 36.67%11.67M | 115.91%8.43M | 151.78%8.26M | 32.66%5.94M | 70.82%21.12M | 191.90%8.54M | 24.81%3.9M | 26.07%3.28M |
| Operating expense | -33.43%10.98M | 15.93%52.71M | -10.37%14.32M | 8.45%10.47M | -22.84%9.78M | 69.43%16.49M | 2.21%45.47M | 37.14%15.98M | 23.09%9.65M | 194.77%12.68M |
| Selling and administrative expenses | 5.13%6.91M | 9.88%30.36M | 10.95%9.37M | 1.75%7.99M | 49.44%9.27M | 2.72%6.57M | 14.37%27.63M | 34.76%8.44M | 22.83%7.85M | 20.74%6.2M |
| -Selling and marketing expense | 50.00%474K | 7.57%1.22M | -78.96%73K | 38.24%470K | 49.74%575K | 37.99%316K | 40.59%1.14M | 138.81%347K | -73.58%340K | 251.78%384K |
| -General and administrative expense | 2.86%6.44M | 9.98%29.13M | 14.81%9.3M | 0.09%7.52M | 49.42%8.69M | 1.41%6.26M | 13.46%26.49M | 13.09%8.1M | 47.14%7.51M | 7.94%5.82M |
| Other operating expenses | -58.98%4.07M | 25.57%22.4M | -34.28%4.95M | 37.67%2.48M | -92.05%515K | 197.45%9.92M | -12.23%17.84M | 39.92%7.53M | 24.22%1.8M | --6.48M |
| Total other operating income | ---- | --49K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Operating profit | 108.92%941K | 26.18%-17.97M | 64.37%-2.65M | 64.57%-2.04M | 83.78%-1.52M | -100.80%-10.55M | 24.20%-24.34M | 14.74%-7.44M | -21.94%-5.75M | -453.03%-9.4M |
| Net non-operating interest income (expenses) | 3,013.33%467K | 619.23%405K | 209.78%101K | 546.43%125K | 0.00%40K | -6.25%15K | -133.91%-78K | -15.00%-92K | -107.05%-28K | 225.00%40K |
| Non-operating interest income | 824.07%499K | 176.07%773K | 495.45%393K | 153.13%162K | -18.48%75K | -6.90%54K | -50.44%280K | -42.11%66K | -84.04%64K | 300.00%92K |
| Non-operating interest expense | -17.95%32K | 2.79%368K | 84.81%292K | -59.78%37K | -32.69%35K | -7.14%39K | 6.87%358K | -18.56%158K | 2,200.00%92K | -5.45%52K |
| Net investment income | -87.37%606K | -76.28%4.8M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 7.44%8.7M | -42.18%8.1M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -57.43%2.77M | 50,023.08%6.52M | ||||||||
| Less:Other special charges | ---- | -56.50%-2.11M | ---- | ---- | ---- | ---- | -10,261.54%-1.35M | ---- | ---- | ---- |
| Less:Write off | ---- | 87.12%-666K | ---- | ---- | ---- | ---- | ---5.17M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 203.87%13.04M | -2.66%5.39M | -49.79%5.86M | -50.64%2.57M | -28.62%4.73M | -5.44%4.29M | 90.36%5.53M | 164.27%11.68M | -62.91%5.21M | 347.27%6.62M |
| Income before tax | 331.52%14.45M | -118.22%-96K | -20.12%3.32M | 216.23%659K | 218.62%3.24M | -793.98%-6.24M | -90.01%527K | -42.97%4.15M | -105.83%-567K | 37.99%-2.73M |
| Income tax | 741.67%202K | 678.43%13.36M | 606.21%13.7M | 424.14%304K | -99.10%3K | 300.00%24K | 55.94%-2.31M | 54.57%-2.71M | -73.87%58K | 22.79%334K |
| Net income | 327.41%14.25M | -574.33%-13.45M | -251.49%-10.39M | 156.80%355K | 205.61%3.24M | -789.77%-6.26M | -73.03%2.84M | -48.19%6.86M | -106.58%-625K | 34.46%-3.07M |
| Net income continuous operations | 327.41%14.25M | -574.33%-13.45M | -251.49%-10.39M | 156.80%355K | 205.61%3.24M | -789.77%-6.26M | -73.03%2.84M | -48.19%6.86M | -106.58%-625K | 34.46%-3.07M |
| Noncontrolling interests | -176.40%-68K | -241.43%-1.53M | -1,534.04%-1.54M | 63.21%-188K | -733.33%-19K | -40.67%89K | -375.46%-449K | -5.62%-94K | -475.74%-511K | -98.64%3K |
| Net income attributable to the company | 325.30%14.31M | -462.83%-11.92M | -227.35%-8.85M | 576.32%543K | 206.12%3.26M | -643.91%-6.35M | -68.26%3.29M | -47.83%6.95M | -101.22%-114K | 37.35%-3.07M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 325.30%14.31M | -462.83%-11.92M | -227.35%-8.85M | 576.32%543K | 206.12%3.26M | -643.91%-6.35M | -68.26%3.29M | -47.83%6.95M | -101.22%-114K | 37.35%-3.07M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 326.92%0.0177 | -475.00%-0.015 | -228.24%-0.0109 | 800.00%0.0007 | 208.11%0.004 | -680.00%-0.0078 | -69.23%0.004 | -48.80%0.0085 | -100.88%-0.0001 | 37.29%-0.0037 |
| Diluted earnings per share | 326.92%0.0177 | -475.00%-0.015 | -228.24%-0.0109 | 800.00%0.0007 | 208.11%0.004 | -680.00%-0.0078 | -69.23%0.004 | -48.80%0.0085 | -100.88%-0.0001 | 37.29%-0.0037 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.